Annual Current Assets
$316.34 M
+$38.84 M+14.00%
31 December 2023
Summary:
Pharming Group NV annual total current assets is currently $316.34 million, with the most recent change of +$38.84 million (+14.00%) on 31 December 2023. During the last 3 years, it has risen by +$53.13 million (+20.19%). PHAR annual current assets is now at all-time high.PHAR Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$282.19 M
+$11.56 M+4.27%
30 September 2024
Summary:
Pharming Group NV quarterly total current assets is currently $282.19 million, with the most recent change of +$11.56 million (+4.27%) on 30 September 2024. Over the past year, it has dropped by -$9.54 million (-3.27%). PHAR quarterly current assets is now -10.80% below its all-time high of $316.34 million, reached on 31 December 2023.PHAR Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.0% | -3.3% |
| 3 y3 years | +20.2% | +16.5% |
| 5 y5 years | +139.6% | +153.4% |
PHAR Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +26.8% | -10.8% | +16.5% |
| 5 y | 5 years | at high | +164.9% | -10.8% | +153.4% |
| alltime | all time | at high | +2731.1% | -10.8% | +3161.7% |
Pharming Group NV Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $282.19 M(+4.3%) |
| June 2024 | - | $270.63 M(-8.7%) |
| Mar 2024 | - | $296.55 M(-6.3%) |
| Dec 2023 | $146.51 M(-1.2%) | $316.34 M(+8.4%) |
| Sept 2023 | - | $291.74 M(+4.7%) |
| June 2023 | - | $278.57 M(+4.7%) |
| Mar 2023 | - | $266.06 M(-4.1%) |
| Dec 2022 | $148.30 M(+0.3%) | $277.50 M(+10.1%) |
| Sept 2022 | - | $252.05 M(-1.9%) |
| June 2022 | - | $256.98 M(+2.4%) |
| Mar 2022 | - | $250.95 M(+0.6%) |
| Dec 2021 | $147.87 M(-4.7%) | $249.44 M(+3.0%) |
| Sept 2021 | - | $242.19 M(-3.6%) |
| June 2021 | - | $251.26 M(-4.0%) |
| Mar 2021 | - | $261.82 M(-0.5%) |
| Dec 2020 | $155.24 M(+13.7%) | $263.21 M(+13.4%) |
| Sept 2020 | - | $232.02 M(+5.6%) |
| June 2020 | - | $219.75 M(+11.4%) |
| Mar 2020 | - | $197.33 M(+65.2%) |
| Dec 2019 | $136.48 M(+20.5%) | $119.44 M(+7.2%) |
| Sept 2019 | - | $111.37 M(-3.2%) |
| June 2019 | - | $115.08 M(+0.8%) |
| Mar 2019 | - | $114.20 M(-13.5%) |
| Dec 2018 | $113.29 M(+21.2%) | $132.05 M(-1.6%) |
| Sept 2018 | - | $134.26 M(+10.1%) |
| June 2018 | - | $121.95 M(+4.7%) |
| Mar 2018 | - | $116.43 M(+10.0%) |
| Dec 2017 | $93.50 M(+37.6%) | $105.87 M(+22.4%) |
| Sept 2017 | - | $86.49 M(+23.7%) |
| June 2017 | - | $69.91 M(-1.0%) |
| Mar 2017 | - | $70.64 M(+8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $67.93 M(+843.6%) | $65.41 M(+42.1%) |
| Sept 2016 | - | $46.01 M(-10.7%) |
| June 2016 | - | $51.53 M(-7.6%) |
| Mar 2016 | - | $55.80 M(-0.1%) |
| Dec 2015 | $7.20 M(-10.0%) | $55.86 M(-10.8%) |
| Sept 2015 | - | $62.63 M(+28.1%) |
| June 2015 | - | $48.89 M(-4.7%) |
| Mar 2015 | - | $51.33 M(-14.1%) |
| Dec 2014 | $8.00 M(-15.0%) | $59.76 M(+36.5%) |
| Sept 2014 | - | $43.76 M(-7.0%) |
| June 2014 | - | $47.05 M(+28.3%) |
| Mar 2014 | - | $36.67 M(+8.0%) |
| Dec 2013 | $9.40 M(-15.3%) | $33.97 M(+52.5%) |
| Sept 2013 | - | $22.27 M(-18.1%) |
| June 2013 | - | $27.20 M(+8.5%) |
| Mar 2013 | - | $25.07 M(+124.4%) |
| Dec 2012 | $11.10 M(-25.7%) | $11.17 M(+29.2%) |
| Sept 2012 | - | $8.65 M(-60.8%) |
| Mar 2012 | - | $22.07 M(+29.4%) |
| Dec 2011 | $14.95 M(+39.8%) | $17.06 M(-24.0%) |
| Sept 2011 | - | $22.45 M(-16.2%) |
| June 2011 | - | $26.79 M(-20.8%) |
| Mar 2011 | - | $33.83 M(-13.0%) |
| Dec 2010 | $10.69 M(-72.7%) | $38.90 M(-2.9%) |
| Sept 2010 | - | $40.06 M(-26.8%) |
| June 2010 | - | $54.75 M(+20.1%) |
| Mar 2010 | - | $45.59 M(+11.4%) |
| Dec 2009 | $39.13 M(-9.7%) | $40.93 M |
| Dec 2008 | $43.32 M(-16.6%) | - |
| Dec 2007 | $51.97 M(+7.4%) | - |
| Dec 2006 | $48.40 M(+350.6%) | - |
| Dec 2005 | $10.74 M | - |
FAQ
- What is Pharming Group NV annual total current assets?
- What is the all time high annual current assets for Pharming Group NV?
- What is Pharming Group NV annual current assets year-on-year change?
- What is Pharming Group NV quarterly total current assets?
- What is the all time high quarterly current assets for Pharming Group NV?
- What is Pharming Group NV quarterly current assets year-on-year change?
What is Pharming Group NV annual total current assets?
The current annual current assets of PHAR is $316.34 M
What is the all time high annual current assets for Pharming Group NV?
Pharming Group NV all-time high annual total current assets is $316.34 M
What is Pharming Group NV annual current assets year-on-year change?
Over the past year, PHAR annual total current assets has changed by +$38.84 M (+14.00%)
What is Pharming Group NV quarterly total current assets?
The current quarterly current assets of PHAR is $282.19 M
What is the all time high quarterly current assets for Pharming Group NV?
Pharming Group NV all-time high quarterly total current assets is $316.34 M
What is Pharming Group NV quarterly current assets year-on-year change?
Over the past year, PHAR quarterly total current assets has changed by -$9.54 M (-3.27%)